Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Pharmacogenet Genomics. 2017 Jun;27(6):213–222. doi: 10.1097/FPC.0000000000000281

Table 2. Summary statistics for genetic data CTCAE grading for COMT, TPMT and ACYP2 CTCAE criteria using worse ear in cases of asymmetric hearing loss.


COMT
Grade 0
(n=26)
Grade 1
(n=8)
Grade 2
(n=41)
Grade 3
(n=35)
Grade 4
(n=6)
rs9332377 CC 18 (22.5%) 4 (5%) 28 (35%) 27 (33.8%) 3 (3.8%)
CT 7 (21.1%) 3 (9.4%) 12 (37.5%) 7 (21.9%) 3 (9.4%)
TT 1 (25%) 1 (25%) 1 (25%) 1 (25%) 0 (0%)
rs4646316 CC 18 (26.1%) 4 (5.8%) 24 (34.8%) 19 (27.5%) 4 (5.8%)
CT 6 (14.3%) 4 (9.5%) 14 (33.3%) 16 (38.1%) 2 (4.8%)
TT 1 (33.3%) 0 (0%) 2 (66.7%) 0 (0%) 0 (0%)
TPMT
rs12201199 AA 18 (19.1%) 7 (7.4%) 33 (35.1%) 30 (31.9%) 6 (6.4%)
AT 7 (33.3%) 1 (4.8%) 8 (38.1%) 5 (23.8%) 0 (0%)
TT 1(100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
rs1142345 TT 22 (22%) 7 (7%) 34 (34%) 31 (31%) 6 (6%)
TC 3 (21.4%) 1 (7.1%) 6 (42.9%) 4 (28.6%) 0 (0%)
CC 1(100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
rs1800460 CC 24 (22.6%) 7 (6.6%) 37 (34.9%) 32 (30.2%) 6 (5.7%)
CT 1 (11.1%) 1 (11.1%) 4 (44.4%) 3 (33.3%) 0 (0%)
TT 1(100%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
ACYP2
Grade 0
(n=31)
Grade 1a
(n=17)
Grade 1b
(n=15)
Grade 2a
(n=5)
Grade2b
(n=10)
Grade 3
(n=32)
Grade 4
(n=5)
rs1872328 GG 29 (27.4%) 16 (15.1%) 10 (9.4%) 5 (4.7%) 10 (9.4%) 31 (29.2%) 5 (4.7%)
GA 1 (16.7%) 1 (16.7%) 4 (66.7%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
AA 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)